Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Credelio Quattro™ CredelioQuattro™-CA1(lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets)
Medication labelWhy this: Advisory · dailymed-animal
Credelio Quattro is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (immature adult and adult Toxocara canis and adult Toxascaris leonina), hookworm (fourth stage larvae, immature adult, and adult Ancylostoma caninum and adult Uncinaria stenocephala), and tapeworm (Dipylidium caninum, Taenia pisiformis, and Echinococcus granulosus) infections. Credelio Quattro kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Amblyomma americanum (lone star tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), Rhipicephalus sanguineus (brown dog tick), and Haemaphysalis longicornis (longhorned tick)] for one month in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater. Credelio Quattro is indicated for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks. Credelio Quattro-CA1 is indicated for the treatment of infestations caused by New World screwworm (Cochliomyia hominivorax) larvae (myiasis) in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater.
- generic_name
- lotilaner, moxidectin, praziquantel, and pyrantel chewable
- product_names
- lotilaner, moxidectin, praziquantel, and pyrantel chewable
- ndc
- 58198-5825, 58198-5825-1, 58198-5825-2, 58198-5825-3, 58198-5825-4, 58198-5825-5, 58198-5825-6, 58198-5826, 58198-5826-1, 58198-5826-2, 58198-5826-3, 58198-5826-4, 58198-5826-5, 58198-5826-6, 58198-5827, 58198-5827-1, 58198-5827-2, 58198-5827-3, 58198-5827-4, 58198-5827-5, 58198-5827-6, 58198-5828, 58198-5828-1, 58198-5828-2, 58198-5828-3, 58198-5828-4, 58198-5828-5, 58198-5829, 58198-5829-1, 58198-5829-2, 58198-5829-3, 58198-5829-4, 58198-5829-5
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en